Jean Reignier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean Reignier has a total of 821 co-authors. Here are the top co-authors by number of shared publications:
Jean-Pierre Quenot
Service de Médecine Intensive-Réanimation, CHU Dijon–Bourgogne, INSERM CIC 1432–Equipe Lipness, Unite Mixté de Recherche (UMR) 1231, Université Bourgogne–Europe, Dijon, France
13 shared publicationsAmélie Le Gouge
INSERM CIC 1415, Centre Hospitalier Regional Universitaire de Tours, Tours, France
11 shared publicationsJérôme Devaquet
Service de réanimation polyvalente, hôpital Foch, Suresnes, France
11 shared publicationsEmmanuelle Mercier
Service de Médecine Intensive Réanimation, Centre Hospitalier Régional Universitaire de Tours Hôpital Bretonneau, Tours, France
10 shared publicationsJean-Baptiste Lascarrou
Service de Médecine Intensive Réanimation, Nantes University Hospital, Nantes, France
10 shared publicationsLaurent Argaud
Hospices Civils de Lyon, Service de Médecine Intensive Réanimation, Hôpital Edouard Herriot, Lyon, France
10 shared publications
Latest Publications
- Open Access
Impact of an early extended rehabilitation programme combining individually tailored nutrition and physical activity on patient outcomes after invasive mechanical ventilation and vasopressor therapy in the ICU: design and conduct of a multicentre, randomised, controlled, open-label, assessor-blinded trial (NUTRIREA-4)
Introduction Survivors of severe critical illness often experience long-lasting physical, quality of life and psychological impairments. Intensive care unit (ICU)-acquired weakness develops early and is associated with prolonged mechanical ventilation, delayed functional recovery, impaired quality of life and greater healthcare utilisation. Nutritional support and early mobilisation are considered key components of ICU care. However, trials have evaluated either nutritional or physical rehabilitation strategies and have not consistently demonstrated long-term benefits. A strong physiological rationale exists for combining nutritional therapy and structured physical rehabilitation. Moreover, most interventions were limited to the ICU stay. The NUTRIREA-4 trial will assess whether an individualised, integrated rehabilitation strategy of nutritional support, physiotherapy and adapted physical activity initiated early in the ICU and continued throughout and after the hospital stay improves long-term physical performance and recovery. NUTRIREA-4 is the first large-scale multicentre randomised controlled trial evaluating such a comprehensive approach in survivors of severe critical illness. Methods and analysis NUTRIREA-4 is a randomised controlled, multicentre, open-label trial comparing two parallel groups of patients receiving invasive mechanical ventilation and vasopressor therapy for shock and randomised to either an individualised rehabilitation programme or usual care. The rehabilitation programme combines goal-directed nutritional support, physiotherapy and adapted physical activity delivered from ICU admission to 12 weeks after the return home. We will include 830 patients in 52 French ICUs. The primary endpoint is the 6-minute walk distance measured by blinded assessors 6 months after randomisation. Secondary outcomes include muscle strength, physical activity, nutritional intake, ICU-acquired infections, quality of life, mortality and psychological recovery. Ethics and dissemination The NUTRIREA-4 trial has been approved by the appropriate ethics committee. Patients are included after informed consent according to French law. The results will be published in international peer-reviewed journals and presented at conferences. Trial registration number NCT06581939.
Open AccessImpact of an early extended rehabilitation programme combining individually tailored nutrition and physical activity on patient outcomes after invasive mechanical ventilation and vasopressor therapy in the ICU: design and conduct of a multicentre, randomised, controlled, open-label, assessor-blinded trial (NUTRIREA-4)
Introduction Survivors of severe critical illness often experience long-lasting physical, quality of life and psychological impairments. Intensive care unit (ICU)-acquired weakness develops early and is associated with prolonged mechanical ventilation, delayed functional recovery, impaired quality of life and greater healthcare utilisation. Nutritional support and early mobilisation are considered key components of ICU care. However, trials have evaluated either nutritional or physical rehabilitation strategies and have not consistently demonstrated long-term benefits. A strong physiological rationale exists for combining nutritional therapy and structured physical rehabilitation. Moreover, most interventions were limited to the ICU stay. The NUTRIREA-4 trial will assess whether an individualised, integrated rehabilitation strategy of nutritional support, physiotherapy and adapted physical activity initiated early in the ICU and continued throughout and after the hospital stay improves long-term physical performance and recovery. NUTRIREA-4 is the first large-scale multicentre randomised controlled trial evaluating such a comprehensive approach in survivors of severe critical illness. Methods and analysis NUTRIREA-4 is a randomised controlled, multicentre, open-label trial comparing two parallel groups of patients receiving invasive mechanical ventilation and vasopressor therapy for shock and randomised to either an individualised rehabilitation programme or usual care. The rehabilitation programme combines goal-directed nutritional support, physiotherapy and adapted physical activity delivered from ICU admission to 12 weeks after the return home. We will include 830 patients in 52 French ICUs. The primary endpoint is the 6-minute walk distance measured by blinded assessors 6 months after randomisation. Secondary outcomes include muscle strength, physical activity, nutritional intake, ICU-acquired infections, quality of life, mortality and psychological recovery. Ethics and dissemination The NUTRIREA-4 trial has been approved by the appropriate ethics committee. Patients are included after informed consent according to French law. The results will be published in international peer-reviewed journals and presented at conferences. Trial registration number NCT06581939.
- Top Cited Papers
- 4 June 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 394 (21) , 2095-2106
High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemic respiratory failure to receive high-flow-oxygen or standard-oxygen therapy. All the patients had a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 or less, a respiratory rate of more than 25 breaths per minute, and pulmonary infiltrate on chest imaging. The primary outcome was death by day 28. A total of 1116 patients underwent randomization. Of these patients, 1110 (556 in the high-flow-oxygen group and 554 in the standard-oxygen group) were included in the analysis. Mortality at day 28 was 14.6% (in 81 of 556 patients) in the high-flow-oxygen group and 14.6% (in 81 of 554 patients) in the standard-oxygen group (difference, -0.05 percentage points; 95% confidence interval [CI], -4.21 to 4.10; P = 0.98). The incidence of intubation by day 28 was 42.4% (in 236 of 556 patients) in the high-flow-oxygen group and 48.4% (in 268 of 554 patients) in the standard-oxygen group (difference, -5.93 percentage points; 95% CI, -11.78 to -0.08). Serious adverse events (cardiac arrest or pneumothorax) occurred during spontaneous breathing in 13 patients (2.3%) in the high-flow-oxygen group and in 6 patients (1.1%) in the standard-oxygen group. Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28. (Funded by the French Ministry of Health and Fisher and Paykel Healthcare; SOHO ClinicalTrials.gov number, NCT04468126.).
- 4 June 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 394 (21) , 2095-2106
Top Cited PapersHigh-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemic respiratory failure to receive high-flow-oxygen or standard-oxygen therapy. All the patients had a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 or less, a respiratory rate of more than 25 breaths per minute, and pulmonary infiltrate on chest imaging. The primary outcome was death by day 28. A total of 1116 patients underwent randomization. Of these patients, 1110 (556 in the high-flow-oxygen group and 554 in the standard-oxygen group) were included in the analysis. Mortality at day 28 was 14.6% (in 81 of 556 patients) in the high-flow-oxygen group and 14.6% (in 81 of 554 patients) in the standard-oxygen group (difference, -0.05 percentage points; 95% confidence interval [CI], -4.21 to 4.10; P = 0.98). The incidence of intubation by day 28 was 42.4% (in 236 of 556 patients) in the high-flow-oxygen group and 48.4% (in 268 of 554 patients) in the standard-oxygen group (difference, -5.93 percentage points; 95% CI, -11.78 to -0.08). Serious adverse events (cardiac arrest or pneumothorax) occurred during spontaneous breathing in 13 patients (2.3%) in the high-flow-oxygen group and in 6 patients (1.1%) in the standard-oxygen group. Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28. (Funded by the French Ministry of Health and Fisher and Paykel Healthcare; SOHO ClinicalTrials.gov number, NCT04468126.).
- 2 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (6) , 1284-1289
Nutrition support in the ICU: current evidence and evolving standards
Nutritional support is a cornerstone of care in critically ill patients, yet the optimal delivery of macronutrient across phases of critical illness remain
- 2 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (6) , 1284-1289
Nutrition support in the ICU: current evidence and evolving standards
Nutritional support is a cornerstone of care in critically ill patients, yet the optimal delivery of macronutrient across phases of critical illness remain
- Open Access
- 29 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16
Physical, psychological, and cognitive function and quality of life in survivors of severe critical illness
Survivors of critical illness frequently experience persistent physical, psychological, and cognitive impairments after intensive care unit (ICU) discharge, which may contribute to reduced quality of life. Previous studies have described these outcomes in heterogeneous ICU populations with variable illness severity and using non-uniform assessment approaches. We conducted a standardized, multimodal assessment with validated scales in a cohort of severely ill ICU patients. This prospective, single-centre observational study included 100 adults (median age 63 years; 69% male) who required invasive mechanical ventilation for at least 48 h and vasopressors for shock. Follow-up was performed three months after ICU discharge. Physical performance was markedly impaired, with a median six-minute walk distance of 285 m (55% of predicted). Symptoms of anxiety, depression, and post-traumatic stress were observed in 35.4%, 32.3%, and 12.5% of patients, respectively. Suspected cognitive impairment was present in 55.7%, and frailty in 51%, of survivors. Older age, higher pre-ICU frailty, and longer ICU length of stay were independently associated with post-ICU frailty. Overall, 69.8% of patients had frailty or psychological impairment and 28.1% had both. These findings in survivors of severe critical illness highlight the need for early, structured, and multimodal post-ICU care pathways targeting this high-risk population.
- 29 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16
Open AccessPhysical, psychological, and cognitive function and quality of life in survivors of severe critical illness
Survivors of critical illness frequently experience persistent physical, psychological, and cognitive impairments after intensive care unit (ICU) discharge, which may contribute to reduced quality of life. Previous studies have described these outcomes in heterogeneous ICU populations with variable illness severity and using non-uniform assessment approaches. We conducted a standardized, multimodal assessment with validated scales in a cohort of severely ill ICU patients. This prospective, single-centre observational study included 100 adults (median age 63 years; 69% male) who required invasive mechanical ventilation for at least 48 h and vasopressors for shock. Follow-up was performed three months after ICU discharge. Physical performance was markedly impaired, with a median six-minute walk distance of 285 m (55% of predicted). Symptoms of anxiety, depression, and post-traumatic stress were observed in 35.4%, 32.3%, and 12.5% of patients, respectively. Suspected cognitive impairment was present in 55.7%, and frailty in 51%, of survivors. Older age, higher pre-ICU frailty, and longer ICU length of stay were independently associated with post-ICU frailty. Overall, 69.8% of patients had frailty or psychological impairment and 28.1% had both. These findings in survivors of severe critical illness highlight the need for early, structured, and multimodal post-ICU care pathways targeting this high-risk population.
- 16 April 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (4) , 651-661
Low versus standard calorie and protein feeding and renal dysfunction in ventilated adults with shock: a NUTRIREA-3 post hoc analysis
Purpose The optimal intake of artificial nutrition in critically ill patients remains unclear. While calorie and protein intakes affect glomerular function in patients with chronic kidney disease, their relation to renal function at the acute phase of intensive care is insufficiently documented. We aimed to study associations of a low-calorie and low-protein diet with renal outcomes in critically ill patients. Methods This post hoc analysis of the NUTRIREA-3 randomized-controlled trial included 3036 mechanically ventilated patients with shock. Calorie and protein intakes during the first 7 days were either low (6 kcal/kg and 0.2–0.4 g protein/kg/d) or standard (25 kcal/kg and 1.0–1.3 g protein/kg/d). The primary outcome was the incidence of acute kidney disease (AKD) during the ICU stay (up to ICU discharge or day 90 after inclusion, whichever occurred first). Results AKD during the ICU stay occurred in 669 (44.6%) low-group patients and 691 (46.1%) standard-group patients (hazard ratio, 0.97; 95% CI 0.88–1.07; P = 0.53). The highest urea level and the urea level at ICU discharge were significantly lower in the low group (P = 0.002). No differences were found for renal replacement therapy requirements or other renal outcomes. The results were similar in patients with early kidney dysfunction, severe organ failures, or end-stage chronic kidney disease. Conclusion In critically ill patients with shock, early low-calorie and low-protein nutrition for 7 days was not associated with worse renal outcomes or mortality compared to standard feeding, even in patients with preexisting renal dysfunction. Visual abstract The alt text for this image may have been generated using AI.
- 16 April 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (4) , 651-661
Low versus standard calorie and protein feeding and renal dysfunction in ventilated adults with shock: a NUTRIREA-3 post hoc analysis
Purpose The optimal intake of artificial nutrition in critically ill patients remains unclear. While calorie and protein intakes affect glomerular function in patients with chronic kidney disease, their relation to renal function at the acute phase of intensive care is insufficiently documented. We aimed to study associations of a low-calorie and low-protein diet with renal outcomes in critically ill patients. Methods This post hoc analysis of the NUTRIREA-3 randomized-controlled trial included 3036 mechanically ventilated patients with shock. Calorie and protein intakes during the first 7 days were either low (6 kcal/kg and 0.2–0.4 g protein/kg/d) or standard (25 kcal/kg and 1.0–1.3 g protein/kg/d). The primary outcome was the incidence of acute kidney disease (AKD) during the ICU stay (up to ICU discharge or day 90 after inclusion, whichever occurred first). Results AKD during the ICU stay occurred in 669 (44.6%) low-group patients and 691 (46.1%) standard-group patients (hazard ratio, 0.97; 95% CI 0.88–1.07; P = 0.53). The highest urea level and the urea level at ICU discharge were significantly lower in the low group (P = 0.002). No differences were found for renal replacement therapy requirements or other renal outcomes. The results were similar in patients with early kidney dysfunction, severe organ failures, or end-stage chronic kidney disease. Conclusion In critically ill patients with shock, early low-calorie and low-protein nutrition for 7 days was not associated with worse renal outcomes or mortality compared to standard feeding, even in patients with preexisting renal dysfunction. Visual abstract The alt text for this image may have been generated using AI.
- 9 March 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (3) , 512-526
Feeding the injured brain: nutrients, dose, timing, and monitoring
Nutrition is a key component of the management of neurocritically ill patients. The healthy brain accounts for up to 25% of total resting energy expenditure (REE), and after injury the brain faces inflammation, altered glucose metabolism, and catabolic stress. This review outlines the evolving science and current practice of nutrition in neurocritical illness, emphasizing pathophysiology, metabolic phases, and individualized strategies. Enteral nutrition remains the preferred route, with early, low-dose initiation within 24–48 h generally recommended. Feeding intolerance, aspiration risk, and altered gastrointestinal motility are common barriers. Parenteral nutrition may be warranted when enteral nutrition is contraindicated or insufficient; however, early initiation of target feeding, independent of the enteral or parenteral route of administration, has shown harm in general ICU populations and remains underexplored in neurocritically ill patients. The role of timing to start feeding, energy and protein dosing, micronutrient supplementation, and metabolic monitoring via indirect calorimetry is discussed, with recent trials questioning traditional targets. Emerging concepts include the ketogenic diet, exogenous lactate, and immunonutrition, all of which aim to optimize recovery and reduce secondary brain injury. Despite promising mechanistic rationale, robust neurocritical-specific data are lacking. Personalized nutrition based on metabolic phenotyping and real-time monitoring to optimize neurocritical nutrition requires further validation. Ultimately, nutritional care in neurocritical settings might benefit from a multidisciplinary integrated approach. Rather than supportive care alone, nutrition could be viewed as a modifiable therapeutic intervention with the potential to influence neurological recovery and long-term outcomes. Visual abstract
- 9 March 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (3) , 512-526
Feeding the injured brain: nutrients, dose, timing, and monitoring
Nutrition is a key component of the management of neurocritically ill patients. The healthy brain accounts for up to 25% of total resting energy expenditure (REE), and after injury the brain faces inflammation, altered glucose metabolism, and catabolic stress. This review outlines the evolving science and current practice of nutrition in neurocritical illness, emphasizing pathophysiology, metabolic phases, and individualized strategies. Enteral nutrition remains the preferred route, with early, low-dose initiation within 24–48 h generally recommended. Feeding intolerance, aspiration risk, and altered gastrointestinal motility are common barriers. Parenteral nutrition may be warranted when enteral nutrition is contraindicated or insufficient; however, early initiation of target feeding, independent of the enteral or parenteral route of administration, has shown harm in general ICU populations and remains underexplored in neurocritically ill patients. The role of timing to start feeding, energy and protein dosing, micronutrient supplementation, and metabolic monitoring via indirect calorimetry is discussed, with recent trials questioning traditional targets. Emerging concepts include the ketogenic diet, exogenous lactate, and immunonutrition, all of which aim to optimize recovery and reduce secondary brain injury. Despite promising mechanistic rationale, robust neurocritical-specific data are lacking. Personalized nutrition based on metabolic phenotyping and real-time monitoring to optimize neurocritical nutrition requires further validation. Ultimately, nutritional care in neurocritical settings might benefit from a multidisciplinary integrated approach. Rather than supportive care alone, nutrition could be viewed as a modifiable therapeutic intervention with the potential to influence neurological recovery and long-term outcomes. Visual abstract
- 28 October 2025
- Published by Elsevier in L'Évolution Psychiatrique
- Vol. 90 (4) , 716-728
Enjeux psychologiques du prélèvement d’organes Maastricht III au sein des équipes de réanimation et de coordination : étude prospective et qualitative
- 28 October 2025
- Published by Elsevier in L'Évolution Psychiatrique
- Vol. 90 (4) , 716-728
Enjeux psychologiques du prélèvement d’organes Maastricht III au sein des équipes de réanimation et de coordination : étude prospective et qualitative
- Open Access
- 6 August 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (8) , e1300
Life-Supporting Treatment Limitations in Patients Who Die Within 48 Hours After ICU Admission: A French, Multicenter, Observational, Exploratory Study
IMPORTANCE: The occurrence of death shortly after ICU admission raises concerns about the appropriateness of providing intensive care to frail patients—many of whom are subsequently subject to decisions to limit life-supporting treatment limitation (LST-L). The proportion of patients who die early and are affected by such limitations remains unknown. OBJECTIVES: The primary objective was to determine the proportion of patients with a decision of LST-L among patients who died within 48 hours after ICU admission. We also conducted analyses to identify variables associated with LST-L and collected staff perceptions. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, observational, multicenter study with data collected immediately after the patient’s death, according to predefined criteria. The study was conducted in 12 ICUs in France. Consecutive patients who died within 48 hours of ICU admission during the study period, in 2022–2023, were included. LST-L decisions were not guided by protocols but were at the discretion of the attending intensivists. MAIN OUTCOMES AND MEASURES: Of 1615 patients admitted to the participating ICUs during the study period, 100 died (6.2%) within 48 hours, including 62 with LST-L. RESULTS: In the LST-L group, age was significantly older (72 yr [64–77.8 yr] vs. 63 yr [59.0–69.8 yr]; p = 0.002), Charlson Comorbidity Index significantly higher (5.5 [2.0–8.0] vs. 4.0 [2.0–5.0]; p < 0.001), and management less invasive compared with the full-care group. By multivariable analysis, male patients were less likely to have LST-L decisions (odds ratio, 0.35; 95% CI, 0.13–0.93; p = 0.03). Most physicians, but a smaller proportion of nurses, perceived LST-L decisions as consensual. For 28 of 100 patients, the intensivist retrospectively deemed the ICU admission not the most suitable option. Patient wishes were rarely considered when making LST-L decisions. Time-limited trials were rarely used. Two-thirds of LST-L decisions were made during on-call hours. CONCLUSIONS AND RELEVANCE: Deaths occurring shortly after ICU admission were usually preceded by LST-L decisions. Efforts are needed to better consider patients’ wishes and to strengthen communication between ICU physicians and nursing staff, to ensure appropriate care—even when patients’ wishes are unknown and alternatives to ICU admission are not straightforward. Such rare and sometimes unforeseeable cases may also reflect unspoken preferences of patients or their families.
- 6 August 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (8) , e1300
Open AccessLife-Supporting Treatment Limitations in Patients Who Die Within 48 Hours After ICU Admission: A French, Multicenter, Observational, Exploratory Study
IMPORTANCE: The occurrence of death shortly after ICU admission raises concerns about the appropriateness of providing intensive care to frail patients—many of whom are subsequently subject to decisions to limit life-supporting treatment limitation (LST-L). The proportion of patients who die early and are affected by such limitations remains unknown. OBJECTIVES: The primary objective was to determine the proportion of patients with a decision of LST-L among patients who died within 48 hours after ICU admission. We also conducted analyses to identify variables associated with LST-L and collected staff perceptions. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, observational, multicenter study with data collected immediately after the patient’s death, according to predefined criteria. The study was conducted in 12 ICUs in France. Consecutive patients who died within 48 hours of ICU admission during the study period, in 2022–2023, were included. LST-L decisions were not guided by protocols but were at the discretion of the attending intensivists. MAIN OUTCOMES AND MEASURES: Of 1615 patients admitted to the participating ICUs during the study period, 100 died (6.2%) within 48 hours, including 62 with LST-L. RESULTS: In the LST-L group, age was significantly older (72 yr [64–77.8 yr] vs. 63 yr [59.0–69.8 yr]; p = 0.002), Charlson Comorbidity Index significantly higher (5.5 [2.0–8.0] vs. 4.0 [2.0–5.0]; p < 0.001), and management less invasive compared with the full-care group. By multivariable analysis, male patients were less likely to have LST-L decisions (odds ratio, 0.35; 95% CI, 0.13–0.93; p = 0.03). Most physicians, but a smaller proportion of nurses, perceived LST-L decisions as consensual. For 28 of 100 patients, the intensivist retrospectively deemed the ICU admission not the most suitable option. Patient wishes were rarely considered when making LST-L decisions. Time-limited trials were rarely used. Two-thirds of LST-L decisions were made during on-call hours. CONCLUSIONS AND RELEVANCE: Deaths occurring shortly after ICU admission were usually preceded by LST-L decisions. Efforts are needed to better consider patients’ wishes and to strengthen communication between ICU physicians and nursing staff, to ensure appropriate care—even when patients’ wishes are unknown and alternatives to ICU admission are not straightforward. Such rare and sometimes unforeseeable cases may also reflect unspoken preferences of patients or their families.
- Open Access
- 22 July 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-9
Characteristics and outcomes of ICU patients with sepsis transmitted by cats and dogs: the PETSEPSIS multicentre retrospective observational cohort study
Millions of households have cats or dogs as pets, and infections due to bites or scratches are increasing, with the most common pathogens being Pasteurella spp., Bartonella spp., Capnocytophaga spp, and Francisella tularensis. The objective of this study was to describe patients admitted to the intensive care unit (ICU) for infection transmitted by cats or dogs, as well as their outcomes. The retrospective multicentre observational cohort study PETSEPSIS included consecutive adults admitted to 46 ICUs in France between 2009 and 2019 for sepsis due to cat or dog bites and/or caused by any of the four above-listed bacteria. We described their features and outcomes and performed univariate and multivariate analyses to identify factors associated with death. We included 174 patients with a median age of 64 [50–74] years; 58.1% were male. The median SAPS II score was 42 [28–58]. Mechanical ventilation was required in 51.2% of patients, for a median duration of 7 [4–13] days. Vasopressor support was used in 53.5%, renal replacement therapy in 19%, and limb amputation in 3.6% of the patients. The median ICU length of stay was 7 [4–16] days. Hospital mortality was 24.1%. The clinical presentation and severity of sepsis were similar across bacteria, although patients with Pasteurella spp. were older and had more comorbidities. Contact with cats were more often reported for Pasteurella spp. and Bartonella spp. infections and contact with dogs for Capnocytophaga spp. infections. Risk factors for hospital mortality present on ICU admission were older age, smoking, preexisting liver disease, high serum creatinine, and anaemia. Neither the type of micro-organism nor the initial antimicrobial treatment was associated with mortality. This large multicentre study shows that infections transmitted by cats and dogs are infrequent reasons for ICU admission but are associated with substantial morbidity and mortality. Mortality was associated with older age and comorbidities but not with the type of microorganism or initial antibiotic treatment.
- 22 July 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-9
Open AccessCharacteristics and outcomes of ICU patients with sepsis transmitted by cats and dogs: the PETSEPSIS multicentre retrospective observational cohort study
Millions of households have cats or dogs as pets, and infections due to bites or scratches are increasing, with the most common pathogens being Pasteurella spp., Bartonella spp., Capnocytophaga spp, and Francisella tularensis. The objective of this study was to describe patients admitted to the intensive care unit (ICU) for infection transmitted by cats or dogs, as well as their outcomes. The retrospective multicentre observational cohort study PETSEPSIS included consecutive adults admitted to 46 ICUs in France between 2009 and 2019 for sepsis due to cat or dog bites and/or caused by any of the four above-listed bacteria. We described their features and outcomes and performed univariate and multivariate analyses to identify factors associated with death. We included 174 patients with a median age of 64 [50–74] years; 58.1% were male. The median SAPS II score was 42 [28–58]. Mechanical ventilation was required in 51.2% of patients, for a median duration of 7 [4–13] days. Vasopressor support was used in 53.5%, renal replacement therapy in 19%, and limb amputation in 3.6% of the patients. The median ICU length of stay was 7 [4–16] days. Hospital mortality was 24.1%. The clinical presentation and severity of sepsis were similar across bacteria, although patients with Pasteurella spp. were older and had more comorbidities. Contact with cats were more often reported for Pasteurella spp. and Bartonella spp. infections and contact with dogs for Capnocytophaga spp. infections. Risk factors for hospital mortality present on ICU admission were older age, smoking, preexisting liver disease, high serum creatinine, and anaemia. Neither the type of micro-organism nor the initial antimicrobial treatment was associated with mortality. This large multicentre study shows that infections transmitted by cats and dogs are infrequent reasons for ICU admission but are associated with substantial morbidity and mortality. Mortality was associated with older age and comorbidities but not with the type of microorganism or initial antibiotic treatment.
- Top Cited PapersOpen Access
- 15 July 2025
- Published by Elsevier in Annals of Intensive Care
- Vol. 15 (1) , 99-26
Expert consensus‑based clinical practice guidelines for nutritional support in the intensive care unit: the French Intensive Care Society (SRLF) and the French-Speaking Group of Pediatric Emergency Physicians and Intensivists (GFRUP)
- 15 July 2025
- Published by Elsevier in Annals of Intensive Care
- Vol. 15 (1) , 99-26
Top Cited PapersOpen AccessExpert consensus‑based clinical practice guidelines for nutritional support in the intensive care unit: the French Intensive Care Society (SRLF) and the French-Speaking Group of Pediatric Emergency Physicians and Intensivists (GFRUP)